Back
AngioDynamics Vs. Perspective Therapeutics Industry Stock Comparison
Buy
58
ANGO
AngioDynamics
Last Price:
8.49
Seasonality Move:
-1.09%
Sell
30
CATX
Perspective Therapeutics
Last Price:
2.90
Seasonality Move:
27.93%
Buy
58
AngioDynamics (ANGO)
is a Buy
Is AngioDynamics a Buy, Sell or Hold?
- The current AngioDynamics [ANGO] share price is $8.93. The Score for ANGO is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- ANGO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $2.97. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANGO Stock Price Chart
What is AngioDynamics's stock price today?
-
The AngioDynamics share price today is $8.93
The current trend is moderately bullish and ANGO is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $2.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
ANGO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.6 | Buy |
Relative Strength Index (14 RSI): | 67.75 | Buy |
Chaikin Money Flow: | -448704 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.63 - 8.61) | Buy |
Bollinger Bands (100): | (6.64 - 8) | Buy |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.48 | Sell |
Relative Strength Index (14 RSI): | 19.82 | Sell |
Chaikin Money Flow: | -1159369 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.75 - 6.55) | Sell |
Bollinger Bands (100): | (7.07 - 15.09) | Sell |
ANGO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.04 | Sell |
20-day SMA: | 7.81 | Buy |
50-day SMA: | 7.18 | Buy |
200-day SMA: | 6.72 | Buy |
8-day EMA: | 8.81 | Buy |
20-day EMA: | 8.13 | Buy |
50-day EMA: | 7.55 | Buy |
200-day EMA: | 7.15 | Buy |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.42 | Sell |
20-day SMA: | 3.79 | Sell |
50-day SMA: | 8.4 | Sell |
200-day SMA: | 12.27 | Sell |
8-day EMA: | 3.4 | Sell |
20-day EMA: | 4.5 | Sell |
50-day EMA: | 7.32 | Sell |
200-day EMA: | 10.16 | Sell |
AngioDynamics Earnings Growth & ANGO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.46 per share, and an increase next year of $0.12 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
AngioDynamics Technical Analysis
Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |